SHAREHOLDER ALERT: Morris Kandinov Investigating MASI, EXTR, POWW, and EP; Shareholders are Encouraged to Contact the Firm
08 janv. 2025 06h00 HE
|
Morris Kandinov, LLP
National law firm Morris Kandinov is investigating Masimo Corporation, Extreme Networks, Inc., AMMO Incorporated, and Empire Petroleum Corporation.
Kuehn Law Encourages Investors of Empire Petroleum Corp to Contact Law Firm
06 janv. 2025 22h11 HE
|
KUEHN LAW, PLLC
Kuehn Law is investigating Empire Petroleum Corp for potential fiduciary breaches. Shareholders should contact Justin Kuehn, Esq.
UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
17 août 2024 11h27 HE
|
Sol-Gel Technologies Ltd.
Sol-Gel reports Second Quarter 2024 Financial Results and provides Corporate Updates
Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
16 août 2024 07h00 HE
|
Sol-Gel Technologies Ltd.
Sol-Gel reports Second Quarter 2024 Financial Results and provides Corporate Updates
Empire Petroleum Announces Commencement of Previously Announced Rights Offering
07 mars 2024 20h51 HE
|
Empire Petroleum Corporation
EMPIRE PETROLEUM ANNOUNCES COMMENCEMENT OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING
BioSig Announces Reduction of its Workforce
20 févr. 2024 10h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a...
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
06 févr. 2024 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and...
BioSig Announces Reverse Stock Split
31 janv. 2024 11h15 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company committed to delivering unprecedented accuracy and...
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
30 janv. 2024 08h30 HE
|
BioSig Technologies, Inc.
Cost Savings Targeted to Reduce Cash Burn by 50% Core Strategy Shifts to Business Development and Distribution Partnerships Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BioSig...
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
06 déc. 2023 14h20 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 06, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...